Explore

@seattlechildrens.org Sep 8, 2026, 6:00 PM

Among the milestones that helped shape the last two decades: PLAT-02, a groundbreaking clinical trial that advanced CAR T-cell immunotherapy and helped transform the future of pediatric research.
To read the full story visit: https://bit.ly/4gynfPq
#SCRI20

20th anniversary graphic for Seattle Children's. Text highlights the PLAT-02 breakthrough in pediatric immunotherapy for relapsed leukemia, established in 2014. Image shows a researcher and a group of children with a sign reading "Cure Factory.

The image shows a person sitting beside a child in a hospital room. Medical equipment and a hospital bed are visible. Text highlights the development of a leading pediatric CAR T-cell research program starting with PLAT-02, involving over 500 patients in Seattle Children's clinical trials to advance innovative therapies.

Laboratory setting with a person in a lab coat working at a counter with scientific equipment and supplies. Text highlights a 93% remission rate for relapsed leukemia from PLAT-02, emphasizing ongoing research and innovation to improve outcomes for children with cancer.

A graphic with a blue background features text about Seattle Children's Research Institute celebrating 20 years of impactful research. It highlights advancements in treatments and improvements in children's health outcomes. The phrases "More birthdays. More milestones. More futures made possible." are emphasized at the bottom.

Terms of Use Privacy Policy Community Standards Help Get the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT